Severely insulin-resistant phenotype 'benefits most from bariatric surgery'

Novel classification of patients with type 2 diabetes might facilitate better targeting of treatment, researchers say

Patients with severe, insulin-resistant diabetes stand to benefit more from bariatric surgery than any other group of patients with the disease, a groundbreaking study shows.

International researchers say their findings might lead to patients being offered treatments tailored to their disease phenotype rather than relying on a one-size-fits-all approach.

The findings expand on the novel data-driven classification of type 2 diabetes into five distinct disease subgroups that was first proposed in 2018.